Development of the optimal composition of tablets with the active substance potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the effect of auxiliary substances on bulk density, bulk density after shrinkage, fluidity and angle of natural slope of powder masses
DOI:
https://doi.org/10.14739/2409-2932.2024.2.300704Keywords:
1,2,4-triazole, pharmaco-technological indicators, tablet, dosage form, direct pressingAbstract
The pharmaceutical industry continually evolves to meet the demands of modern society for high-quality medications. One avenue of this advancement involves exploring new technologies for manufacturing tablet formulations that adhere to contemporary quality standards. An integral aspect of this process is the careful selection of optimal excipients that preserve the pharmacological activity of the active substance to the greatest extent possible. Investigating the impact of various excipients on the tablet compression process is pivotal to addressing this challenge. Therefore, the study of the influence of excipients on the pharmaco-technological properties of tablets with potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate is an important aspect, so as this substance has pronounced hepatoprotective and antioxidant properties.
The aim of the work was to study the effect of excipients on the pharmaco-technological parameters of tablets with the active ingredient potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate obtained by the method direct pressing.
Materials and methods. Active substance – potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate, auxiliary substances (excipients based on microcrystalline cellulose, auxiliary substances based on granulated sugars, lubricants, lubricants). The powder mixtures were checked for bulk density, bulk density after compaction, flowability and angle of natural slope. The tablets were pressed by the direct pressing method. The effect of auxiliary substances on the pressing process was studied.
Results. The conducted studies show that the powder mass of potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate and auxiliary substances was characterized by good pharmaco-technological indicators – bulk density and bulk density after compaction, fluidity and angle of natural slope. Further, during the tableting process, it was confirmed that the powder mass has satisfactory properties. In almost all series of experiments, the process of pressing the tablets took place without difficulties, the matrix was evenly filled, but the force of pushing the tablets out of the matrix was different.
Conclusions. The study involving 16 excipients, including fillers, disintegrants, and lubricants to develop the composition and technology was conducted of a new tablet medicine containing potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-yl)thio)acetate. This comprehensive examination enabled us to identify the optimal auxiliary substances that fulfill all the pharmaco-technological requirements stipulated by the State Pharmacopoeia of Ukraine for tablet formulations.
References
Barrett JS. Phases of drug development and drug development paradigms. In: Fundamentals of Drug Development [Internet]. 2022. p. 79-100. doi: https://doi.org/10.1002/9781119913276.ch5
Biala G, Kedzierska E, Kruk-Slomka M, Orzelska-Gorka J, Hmaidan S, Skrok A, et al. Research in the field of drug design and development. Pharmaceuticals. 2023 Sept 11;16(9):1283. doi: https://doi.org/10.3390/ph16091283
Abaci A, Gedeon C, Kuna A, Guvendiren M. Additive manufacturing of oral tablets: Technologies, materials and printed tablets. Pharmaceutics. 2021;13(2):156. doi: https://doi.org/10.3390/pharmaceutics13020156
Tovey G. Pharmaceutical formulation: The Science and Technology of dosage forms. London, UK: Royal Society of Chemistry; 2018. doi: https://doi.org/10.1039/9781782620402
Shcherbyna R. An investigation of the pharmacokinetics and potential metabolites of potassium 2-((4-amino-5-(morfolinometyl)-4H-1, 2, 4-triazol-3-yl) thio) acetate on rats. Journal of Faculty of Pharmacy of Ankara University. 2020;44(2):233-41. doi: https://doi.org/10.33483/jfpanu.681611
Vashchyk Y, Shcherbyna R, Parchenko V, Bushueva I, Gutyj B, Fotina H, et al. Histological study of a corrective influence of a compound potassium 2-((4-amino-5-(morpholinomethyl)-4H-1, 2, 4-triazol-3-yl) thio) acetate (PKR-173) on the state of chicken's liver under infection by pseudomonas aeruginosa. Journal of Faculty of Pharmacy of Ankara University. 2020;44(1):1-17. doi: https://doi.org/10.33483/jfpanu.567757
Shcherbyna R, Vashchyk Y. The research of 1,2,4-triazole derivatives hepatoprotective activity under tetracycline and infectious hepatitis. Journal of Faculty of Pharmacy of Ankara University. 2019;43(2):135-46. doi: https://doi.org/10.33483/jfpau.487173
Shcherbyna RO, Vashchyk YV. Histological study of potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-yl)thio)acetate (PKR-173) corrective influence on the chickens liver state in the condition of tetracycline hepatitis. Zaporozhye medical journal. 2018;20(3):404-12. doi: https://doi.org/10.14739/2310-1210.2018.3.130488
Shcherbyna RО, Samura ТО, Kyrychko BP, Zvenihorodska ТV, Hyrenko IV. The research of ammonium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazole-3-yl) thio) acetate (PKR-177) influence on biochemical indices in rats blood under hepatitis initiated by tetrachloride methane. Zaporozhye medical journal. 2017;19(6):819-22. doi: https://doi.org/10.14739/2310-1210.2017.6.115304
Shcherbyna RO, Panasenko OI, Knysh YH. [The studying of antioxidant activity of salts 2-((4-R-3-(morpholinomethylen)-4H-1,2,4-triazole-5-yl) thio) acetic acids]. Ukrainian biopharmaceutical journal. 2016;(1):37-48. Ukrainian. doi: https://doi.org/10.24959/ubphj.16.7
Walker GM, Holland CR, Ahmad MMN, Craig DQM. Influence of process parameters on fluidised hot-melt granulation and tablet pressing of pharmaceutical powders. Chemical Engineering Science. 2005;60(14):3867-77. doi: https://doi.org/10.1016/j.ces.2005.02.007
Pertsev IM, Dmytriievskyi DI, Rybachuk VD, Khomenko VM, Hudzenko OP, Kotenko OM, et al. Dopomizhni rechovyny v tekhnolohii likiv: vplyv na tekhnolohichni, spozhyvchi, ekonomichni kharakterystyky i terapevtychnu efektyvnist [Excipients in drug technology: influence on technological, consumer, economical characteristics and therapeutic effective-ness]. Kharkiv: Zoloti storinky; 2010. Ukrainian.
Hroshovyi TA, Martsenyuk VP, Kucherenko LI, Vronska LV, Huryeyeva CM. Matematychne planuvannia eksperymentu pry provedenni naukovykh doslidzhen v farmatsii [Mathematical planning of experiment in pharmacy]. Ternopil: Ukrmedknyha; 2008. Ukrainian.
Hroshovy TA, Beley NM, Kucherenko LI, Vasenda MM, Markiv NV, Tryhubchak OV, et al. [Optimization of technological processes of drugs creation bymeans of mathematical planning of experiment]. Farmatsevtychnyi chasopys. 2007;(1):21-9. Available from: https://ojs.tdmu.edu.ua/index.php/pharm-chas/article/view/3107
Derzhavna Farmakopeia Ukrainy [The State Pharmacopoeia of Ukraine]. 2nd ed. Vol. 1. Kharkiv, (UA): State Enterprise Ukrainian Scientific Pharmacopoeial Center of Medicines Quality; 2015. Ukrainian.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
